[1]黄晓东,袁登荣△,方弘伟,等.中西医结合治疗肝肾亏虚型骨质疏松性胸腰椎骨折的临床观察[J].中国中医骨伤科杂志,2026,34(04):36-41.[doi:10.20085/j.cnki.issn1005-0205.260406]
　HUANG Xiaodong,YUAN Dengrong,FANG Hongwei,et al.Clinical Observation of Traditional Chinese and Western Medicine Combined Therapy for Osteoporotic Thoracolumbar Fracture with Liver and Kidney Deficiency[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2026,34(04):36-41.[doi:10.20085/j.cnki.issn1005-0205.260406]
点击复制

中西医结合治疗肝肾亏虚型骨质疏松性胸腰椎骨折的临床观察()

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第34卷
期数:
2026年04期
页码:
36-41
栏目:
临床研究
出版日期:
2026-04-10

文章信息/Info

Title:
Clinical Observation of Traditional Chinese and Western Medicine Combined Therapy for Osteoporotic Thoracolumbar Fracture with Liver and Kidney Deficiency
文章编号:
1005-0205(2026)04-0036-06
作者:
黄晓东1; 袁登荣1△; 方弘伟1; 盛翔1; 于航1; 陈良飞1
1金华市中医医院(浙江 金华,321000)
Author(s):
HUANG Xiaodong1; YUAN Dengrong1; 2△; FANG Hongwei1; SHENG Xiang1; YU Hang1; CHEN Liangfei1
1Jinhua Hospital of Traditional Chinese Medicine,Jinhua 321000,Zhejiang China.
关键词:
骨质疏松性胸腰椎骨折;  经皮椎体成形术;  肝肾亏虚;  肝肾同源;  肝肾并重;  钱氏补肝益肾壮骨方
Keywords:
osteoporotic thoracolumbar fracture;  percutaneous vertebroplasty;  liver and kidney deficiency;  liver and kidney share the same origin;  equal emphasis on liver and kidney;  Qian's Bugan Yishen Zhuanggu decoction
分类号:
R683.2
DOI:
10.20085/j.cnki.issn1005-0205.260406
文献标志码:
A
摘要:
目的:探讨在中医“肝肾同源”理论指导下,运用中西医结合方法治疗肝肾亏虚型骨质疏松性胸腰椎骨折的临床疗效。方法:选取2024年1月至2025年4月收治的肝肾亏虚型骨质疏松性胸腰椎骨折患者140例,随机分为两组,观察组和对照组各70例。对照组采用术前塞来昔布口服镇痛+经皮椎体成形术+术后鲑降钙素鼻喷雾剂治疗,观察组采用术前手法复位+经皮椎体成形术+术后鲑降钙素鼻喷剂+口服钱氏补肝益肾壮骨方治疗。分析和比较两组患者治疗前后的中医证候评分、VAS评分、骨代谢水平和骨密度变化,验证基于“肝肾同源”理论、从“肝肾并重”论治肝肾亏虚型骨质疏松性胸腰椎骨折的临床疗效。结果:两组术后中医证候评分、VAS评分均较术前明显改善,差异有统计学意义(P<0.05),观察组术后中医证候评分、VAS评分较对照组改善更明显,差异有统计学意义(P<0.05); 两组在改善骨代谢、提高骨密度方面均有疗效,差异有统计学意义(P<0.05),观察组调节骨代谢、提高骨密度较对照组改善更为明显,差异有统计学意义(P<0.05)。结论:以“肝肾同源”理论为指导,经皮椎体成形术结合手法复位及钱氏补肝益肾壮骨方治疗肝肾亏虚型骨质疏松性胸腰椎骨折,可明显改善患者术后残余腰痛症状,调节骨代谢和提高骨密度,加快术后康复。
Abstract:
Objective:To investigate the clinical efficacy of combined Chinese and Western medicine treatment for osteoporotic thoracolbar fractures(OTF)associated with liver and kidney deficiency syndrome,guided by the traditional Chinese medicine theory of “liver and kidney of the same origin”.Methods:A total of 140 patients with OTF of liver and kidney deficiency syndrome,treated from January 2024 to April 2025,were randomly assigned to two groups:70 patients in the observation group and 70 patients in the control group.The control group was treated with preoperative oral celecoxib forgesia percutaneous vertebroplasty(PVP)postoperative salmon calcitonin nasal spray,and the observation group was treated with preoperative manual reduction PVP postoperative salmon calonin nasal spray oral Qian's Bugan Yishen Zhuanggu decoction.The traditional Chinese medicine syndrome score,VAS score,bone metabolism and bone density change before and after treatment were analyzed and compared between the two groups of patients,and the clinical efficacy of treating OTF with liver and kidney deficiency syndrome based on the “liver and kidney of the same origin” was verified.Results:After the operation,the traditional Chinese medicine syndrome score and VAS score of the two groups were improved significantly compared with those before the operation(P<0.05),and the improvement of the traditional Chinese medicine syndrome score,and VAS score in the observation group was significantly greater than that in the control group(P<0.05); Both groups effectively improved bone metabolism and increased bone mineral density(P<0.5),and the improvement of the observation group in regulating bone metabolism and increasing bone mineral density was more significant than that of the control group(P<0.05).Conclusion:Guided by the theory of “liver and kidney of the same origin”,PVP combined with manual reduction and Qian's Bugan Yishen Zhuanggu decoction can significantly improve the residual low back pain after surgery,regulate bone metabolism and improve bone density,and accelerate postoperative rehabilitation.

参考文献/References:

[1] 中华医学会骨科学分会.骨质疏松性骨折诊疗指南(2022年版)[J].中华骨科杂志,2022,42(22):1473-1491.
[2] 赵敏,何承建.骨填充网袋治疗骨质疏松性椎体骨折不愈合的疗效观察[J].中国中医骨伤科杂志,2019,27(12):74-75.
[3] 许正伟,郝定均,程黎明,等.骨质疏松性椎体压缩骨折椎体强化术后康复治疗指南(2022版)[J].中华创伤杂志,2022,38(11):961-972.
[4] 吕昊,彭和兵,司捷.低黏度PKP与高黏度PVP治疗骨质疏松性椎体压缩骨折的疗效比较[J].中国中医骨伤科杂志,2020,28(3):44-47.
[5] 国家食品药品监管管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:356-360.
[6] 中国中西医结合学会骨伤科专业委员会.骨质疏松症中西医结合诊疗指南[J].中华医学杂志,2019,99(45):3524-3533.
[7] SHOJI M M,INGALL E M,ROZENTAL T D.Upper extremity fragility fractures[J].The Journal of Hand Surgery,2021,46(2):126-132.
[8] MUSBAHI O,ALI A M,HASSANY H,et al.Vertebral compression fractures[J].British Journal of Hospital Medicine,2018,79(1):36-40.
[9] CHEN C J,ALQWBANI M,ZHAO J,et al.Effects of teriparatide versus salmon calcitonin therapy for the treatment of osteoporosis in Asia:a meta-analysis of randomized controlled trials[J].Endocrine,Metabolic & Immune Disorders Drug Targets,2021,21(5):932-942.
[10] PROST S,PESENTI S,FUENTES S,et al.Treatment of osteoporotic vertebral fractures[J].Orthopaedics & Traumatology:Surgery & Research,2021,107(1S):102779.
[11] POSTLER A,POSTEN C,SCHUBERT M,et al.Patients risk for mortality at 90 days after proximal femur fracture:a retrospective study in a tertiary care hospital[J].BMC Geriatrics,2024,24(1):130.
[12] WANG Z W,WANG G Y,LIU D K,et al.Risk factors for residual back pain after PVP treatment for osteoporotic thoracolumbar compression fractures:a retrospective cohort study[J].World Neurosurgery,2023,180:e484-e493.
[13] LOU S,SHI X,ZHANG X,et al.Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures:a meta-analysis of randomized controlled trials[J].Osteoporosis International,2019,30(12):2369-2380.
[14] MARCELO MARKARIAN P L,MORIONES S,ZILIO A,et al.Vertebroplasty and kyphoplasty:complications,avoidance,and technical notes in our 7 years' experience[J].Global Spine Journal,2015,5(S1):1554490.
[15] WATANABE K,KATSUMI K,OHASHI M,et al.Surgical outcomes of spinal fusion for osteoporotic vertebral fracture in the thoracolumbar spine:comprehensive evaluations of 5 typical surgical fusion techniques[J].Journal of Orthopaedic Science,2019,24(6):1020-1026.
[16] 朱镕辉,胡钧,陈艺博,等.老年骨质疏松性椎体压缩骨折非手术治疗进展[J].辽宁中医药大学学报,2023,25(7):202-206.
[17] 何寅锐,张通海,陈世洲,等.基于肝脾肾讨论原发性骨质疏松症共病[J].临床个性化医学,2024,3(4):2512-2518.
[18] 张路,罗宗键.从肝肾同源理论探讨骨质疏松症与肌少症的关系[J].实用医学研究,2022,4(2):18-19.
[19] 杨婉,王兆林,王盖昊,等.“肝肾同源”理论在慢性乙型病毒性肝炎发病机制中的应用分析[J].中国中医基础医学杂志,2016,22(11):1499-1500.
[20] 涂杜鑫,卢敏.基于筋骨并重分析加味独活寄生合剂诊治膝骨关节炎[J].现代中医药,2022,42(4):84-87.
[21] 金连峰,顾炜,孙富通,等.基于“肝肾同源”理论探讨左、右归丸对TLR4/MyD88/NF-κB信号的影响及治疗骨性关节炎模型的作用机制研究[J].时珍国医国药,2023,34(3):597-600.
[22] DENG D L,LIAN Z,CUI W F,et al.Function of low back muscle exercise:preventive effect of refracture analysis of postoperative vertebral fractures[J].Der Orthopade,2019,48(4):337-342.
[23] JIN J,SHEN W H.Long-term therapeutic effect of percutaneous kyphoplasty combined with & without back muscle rehabilitation exercise in elderly patients:a comparative study[J].Pakistan Journal of Medical Sciences,2022,38(6):1595-1600.
[24] ZHANG L,ZHENG Y L,WANG R,et al.Exercise for osteoporosis:a literature review of pathology and mechanism[J].Frontiers in Immunology,2022,13:1005665.
[25] 黄晓东,钱毓萍,翟波,等.钱氏补肾壮骨方加减治疗骨质疏松症35例[J].中国中医药科技,2017,24(6):803-804.
[26] 刘华,胡梁深,范少勇.补肾壮骨汤联合经皮椎体后凸成形术治疗骨质疏松性椎体压缩性骨折临床观察[J].广州中医药大学学报,2020,37(1):46-49.
[27] SHI C G,HUANG P,KANG H,et al.Glucocorticoid inhibits cell proliferation in differentiating osteoblasts by microRNA-199a targeting of WNT signaling[J].Journal of Molecular Endocrinology,2015,54(3):325-337.
[28] 陈庆贤,刘丽霞,陈青青,等.补肾健脾壮骨方联合唑来膦酸对绝经后骨质疏松症骨代谢及预后的影响探究[J].中华中医药学刊,2022,40(2):112-114.
[29] 黄奎,邹季.补骨脂素对骨质疏松小鼠骨代谢指标和生物力学的影响[J].生物骨科材料与临床研究,2017,14(6):11-13.
[30] 郝芳卉,赵刚,白爽.蛇床子素对牙周炎正畸大鼠牙周组织中TNF-α表达影响的研究[J].微量元素与健康研究,2020,37(2):3-4.
[31] 曲永嘉,孙晓伟,周国兴,等.基于网络药理学和分子对接探究杜仲防治骨质疏松作用机制[J].特产研究,2023,45(1):39-49.
[32] 梅杰,何强,孙欣,等.淫羊藿苷促进成骨细胞增殖分化的非核效应信号通路[J].中国组织工程研究,2023,27(20):3129-3135.
(收稿日期:2025-09-25)

备注/Memo

备注/Memo:
基金项目:金华市中医药科技计划项目重大重点项目(2024ZD01)
△通信作者 E-mail:443846366@qq.com
更新日期/Last Update: 2026-04-15